Moderna (NASDAQ: MRNA) president’s RSUs vest as 991 shares withheld for taxes
Rhea-AI Filing Summary
For Moderna, Inc. (MRNA), President Stephen Hoge reported the vesting and settlement of restricted stock units into common stock. On August 27 and 28, 2026, RSUs covering a total of 2,048 common shares were converted on a one-for-one basis, and corresponding common shares were acquired. In connection with these vests, a total of 991 common shares were withheld to satisfy tax withholding obligations at prices between about $143 and $150 per share. Following these transactions, Hoge also reports indirect holdings of 4,116 common shares through Valhalla, LLC and 151,933 common shares held by a trust for the benefit of his spouse and children, for which he disclaims Section 16 beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F5 | 611 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 611 | -- | -- |
| Tax Withholding | Common Stock F2 | 296 | $142.77 | $42K |
| Exercise | Restricted Stock Units F1, F4 | 1,437 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,437 | -- | -- |
| Tax Withholding | Common Stock F2 | 695 | $149.66 | $104K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Footnotes (5)
- F1. Restricted stock units convert into common stock on a one-for-one basis.
- F2. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F3. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- F4. 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F5. 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
Section 16 beneficial ownership regulatory
pecuniary interest financial
indirect ownership financial
FAQ
What insider equity transactions did MRNA President Stephen Hoge report on this Form 4?
What RSU conversions did Stephen Hoge report for Moderna (MRNA)?
What indirect holdings of Moderna (MRNA) stock does Stephen Hoge report?
Were Stephen Hoge’s Moderna (MRNA) transactions open-market buys or sells?
AI-generated analysis. How Rhea-AI works. Not financial advice.